Historique
Rapport
Assessment of the threat posed by highly potent synthetic opioids in Europe: A scenario-based analysis to inform options for response -
Auteur(s) :
EUDA (European Union Drugs Agency)
Année
2026
Page(s) :
57 p.
Langue(s) :
Anglais
Éditeur(s) :
Lisbon : European Union Drugs Agency (EUDA)
Collection :
Threat assessment
ISBN :
978-92-9408-140-7
Domaine :
Drogues illicites
Discipline :
MAR (Marchés / Markets)
Thésaurus géographique
EUROPE
Organismes
EUDA
Thésaurus mots-clés
OPIOIDES
;
DROGUES DE SYNTHESE
;
MARCHE DE LA DROGUE
;
PHENOMENE EMERGENT
;
SURVEILLANCE EPIDEMIOLOGIQUE
;
LUTTE
;
NALOXONE
;
NITAZENES
;
SECURITE
;
FACTEUR DE RISQUE
;
PRODUIT ILLICITE
;
CONTREFACON
;
RECOMMANDATION
Résumé :
This threat assessment presents a scenario-based analysis of the potential risks posed by highly potent synthetic opioids (HPSOs) in Europe over the next two years. Drawing on available early warning signals, forensic and clinical data, and expert input, it examines how HPSO-related harms could evolve under different conditions and what this means for preparedness across health and security sectors.
The report highlights the rapid emergence and high-risk profile of these substances, including their potential to cause severe harm at very low doses and to appear in misrepresented products, exposing both established high-risk opioid users and wider populations. It identifies key uncertainties shaping future developments and presents two plausible scenarios, supported by a set of priority actions to strengthen early detection, coordination and response capacity.
Designed as a forward-looking preparedness tool rather than a predictive model, the assessment supports policymakers and practitioners in anticipating risks, reducing delays in response and enhancing Europe’s readiness to respond to emerging opioid threats. [Editor's abstract]
The report highlights the rapid emergence and high-risk profile of these substances, including their potential to cause severe harm at very low doses and to appear in misrepresented products, exposing both established high-risk opioid users and wider populations. It identifies key uncertainties shaping future developments and presents two plausible scenarios, supported by a set of priority actions to strengthen early detection, coordination and response capacity.
Designed as a forward-looking preparedness tool rather than a predictive model, the assessment supports policymakers and practitioners in anticipating risks, reducing delays in response and enhancing Europe’s readiness to respond to emerging opioid threats. [Editor's abstract]
Autre(s) lien(s) :
News release (26/06/2026)